カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗精神病薬の世界市場見通し2023年-2029年

◆英語タイトル：Antipsychotic Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5689）◆商品コード：MMG23JU5689
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：116
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Antipsychotic Drug Market 調査レポートは次の情報を含め、グローバルにおけるの抗精神病薬市場規模と予測を収録しています。・世界の抗精神病薬市場：売上、2018年-2023年、2024年-2029年
・世界の抗精神病薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗精神病薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「第一世代抗精神病薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗精神病薬のグローバル主要企業は、Johnson & Johnson、 Pfizer、 Eli Lilly、 Bristol Myers Squibb、 AstraZeneca、 Sumitomo Dainippon Pharma、 Allergan、 Novartis、 Cardinal Health、 Sun Pharmaceutical Industries、 GlaxoSmithKline、 Sanis Health、 Qilu Pharmaceutical、 Otsuka Pharmaceutical、 Vanda Pharmaceuticals、 H.Lundbeck、 Organon、 Hansoh、 Hengrui、 Nhwa Group、 Yangtze River Pharmaceutical Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗精神病薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗精神病薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗精神病薬市場：タイプ別市場シェア、2022年
・第一世代抗精神病薬、第二世代抗精神病薬、第三世代抗精神病薬

世界の抗精神病薬市場：用途別、2018年-2023年、2024年-2029年
世界の抗精神病薬市場：用途別市場シェア、2022年
・双極性障害I型障害、統合失調症、統合失調感情障害、その他

世界の抗精神病薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗精神病薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗精神病薬のグローバル売上、2018年-2023年
・主要企業における抗精神病薬のグローバル売上シェア、2022年
・主要企業における抗精神病薬のグローバル販売量、2018年-2023年
・主要企業における抗精神病薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Johnson & Johnson、 Pfizer、 Eli Lilly、 Bristol Myers Squibb、 AstraZeneca、 Sumitomo Dainippon Pharma、 Allergan、 Novartis、 Cardinal Health、 Sun Pharmaceutical Industries、 GlaxoSmithKline、 Sanis Health、 Qilu Pharmaceutical、 Otsuka Pharmaceutical、 Vanda Pharmaceuticals、 H.Lundbeck、 Organon、 Hansoh、 Hengrui、 Nhwa Group、 Yangtze River Pharmaceutical Group

*************************************************************

・調査・分析レポートの概要
抗精神病薬市場の定義
市場セグメント
世界の抗精神病薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗精神病薬市場規模
世界の抗精神病薬市場規模：2022年 VS 2029年
世界の抗精神病薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗精神病薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗精神病薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：第一世代抗精神病薬、第二世代抗精神病薬、第三世代抗精神病薬
抗精神病薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：双極性障害I型障害、統合失調症、統合失調感情障害、その他
抗精神病薬の用途別グローバル売上・予測

・地域別市場分析
地域別抗精神病薬市場規模 2022年と2029年
地域別抗精神病薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Johnson & Johnson、 Pfizer、 Eli Lilly、 Bristol Myers Squibb、 AstraZeneca、 Sumitomo Dainippon Pharma、 Allergan、 Novartis、 Cardinal Health、 Sun Pharmaceutical Industries、 GlaxoSmithKline、 Sanis Health、 Qilu Pharmaceutical、 Otsuka Pharmaceutical、 Vanda Pharmaceuticals、 H.Lundbeck、 Organon、 Hansoh、 Hengrui、 Nhwa Group、 Yangtze River Pharmaceutical Group
...

This report aims to provide a comprehensive presentation of the global market for Antipsychotic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotic Drug. This report contains market size and forecasts of Antipsychotic Drug in global, including the following market information:
Global Antipsychotic Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Antipsychotic Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
First Generation Antipsychotics Drug Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Antipsychotic Drug include Johnson & Johnson, Pfizer, Eli Lilly, Bristol Myers Squibb, AstraZeneca, Sumitomo Dainippon Pharma, Allergan, Novartis and Cardinal Health, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antipsychotic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antipsychotic Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Antipsychotic Drug Market Segment Percentages, by Type, 2022 (%)
First Generation Antipsychotics Drug
Second Generation Antipsychotics Drug
Third generation Antipsychotics Drug
Global Antipsychotic Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Antipsychotic Drug Market Segment Percentages, by Application, 2022 (%)
Bipolar I Disorder
Schizophrenia
Schizoaffective Disorder
Others
Global Antipsychotic Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Antipsychotic Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antipsychotic Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antipsychotic Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Pfizer
Eli Lilly
Bristol Myers Squibb
AstraZeneca
Sumitomo Dainippon Pharma
Allergan
Novartis
Cardinal Health
Sun Pharmaceutical Industries
GlaxoSmithKline
Sanis Health
Qilu Pharmaceutical
Otsuka Pharmaceutical
Vanda Pharmaceuticals
H.Lundbeck
Organon
Hansoh
Hengrui
Nhwa Group
Yangtze River Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antipsychotic Drug, market overview.
Chapter 2: Global Antipsychotic Drug market size in revenue.
Chapter 3: Detailed analysis of Antipsychotic Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antipsychotic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Antipsychotic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antipsychotic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antipsychotic Drug Overall Market Size
2.1 Global Antipsychotic Drug Market Size: 2022 VS 2029
2.2 Global Antipsychotic Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antipsychotic Drug Players in Global Market
3.2 Top Global Antipsychotic Drug Companies Ranked by Revenue
3.3 Global Antipsychotic Drug Revenue by Companies
3.4 Top 3 and Top 5 Antipsychotic Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antipsychotic Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antipsychotic Drug Players in Global Market
3.6.1 List of Global Tier 1 Antipsychotic Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Antipsychotic Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Antipsychotic Drug Market Size Markets, 2022 & 2029
4.1.2 First Generation Antipsychotics Drug
4.1.3 Second Generation Antipsychotics Drug
4.1.4 Third generation Antipsychotics Drug
4.2 By Type – Global Antipsychotic Drug Revenue & Forecasts
4.2.1 By Type – Global Antipsychotic Drug Revenue, 2018-2023
4.2.2 By Type – Global Antipsychotic Drug Revenue, 2024-2029
4.2.3 By Type – Global Antipsychotic Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Antipsychotic Drug Market Size, 2022 & 2029
5.1.2 Bipolar I Disorder
5.1.3 Schizophrenia
5.1.4 Schizoaffective Disorder
5.1.5 Others
5.2 By Application – Global Antipsychotic Drug Revenue & Forecasts
5.2.1 By Application – Global Antipsychotic Drug Revenue, 2018-2023
5.2.2 By Application – Global Antipsychotic Drug Revenue, 2024-2029
5.2.3 By Application – Global Antipsychotic Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Antipsychotic Drug Market Size, 2022 & 2029
6.2 By Region – Global Antipsychotic Drug Revenue & Forecasts
6.2.1 By Region – Global Antipsychotic Drug Revenue, 2018-2023
6.2.2 By Region – Global Antipsychotic Drug Revenue, 2024-2029
6.2.3 By Region – Global Antipsychotic Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Antipsychotic Drug Revenue, 2018-2029
6.3.2 US Antipsychotic Drug Market Size, 2018-2029
6.3.3 Canada Antipsychotic Drug Market Size, 2018-2029
6.3.4 Mexico Antipsychotic Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Antipsychotic Drug Revenue, 2018-2029
6.4.2 Germany Antipsychotic Drug Market Size, 2018-2029
6.4.3 France Antipsychotic Drug Market Size, 2018-2029
6.4.4 U.K. Antipsychotic Drug Market Size, 2018-2029
6.4.5 Italy Antipsychotic Drug Market Size, 2018-2029
6.4.6 Russia Antipsychotic Drug Market Size, 2018-2029
6.4.7 Nordic Countries Antipsychotic Drug Market Size, 2018-2029
6.4.8 Benelux Antipsychotic Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Antipsychotic Drug Revenue, 2018-2029
6.5.2 China Antipsychotic Drug Market Size, 2018-2029
6.5.3 Japan Antipsychotic Drug Market Size, 2018-2029
6.5.4 South Korea Antipsychotic Drug Market Size, 2018-2029
6.5.5 Southeast Asia Antipsychotic Drug Market Size, 2018-2029
6.5.6 India Antipsychotic Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Antipsychotic Drug Revenue, 2018-2029
6.6.2 Brazil Antipsychotic Drug Market Size, 2018-2029
6.6.3 Argentina Antipsychotic Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Antipsychotic Drug Revenue, 2018-2029
6.7.2 Turkey Antipsychotic Drug Market Size, 2018-2029
6.7.3 Israel Antipsychotic Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Antipsychotic Drug Market Size, 2018-2029
6.7.5 UAE Antipsychotic Drug Market Size, 2018-2029
7 Antipsychotic Drug Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Antipsychotic Drug Major Product Offerings
7.1.4 Johnson & Johnson Antipsychotic Drug Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Antipsychotic Drug Major Product Offerings
7.2.4 Pfizer Antipsychotic Drug Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Antipsychotic Drug Major Product Offerings
7.3.4 Eli Lilly Antipsychotic Drug Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Bristol Myers Squibb
7.4.1 Bristol Myers Squibb Company Summary
7.4.2 Bristol Myers Squibb Business Overview
7.4.3 Bristol Myers Squibb Antipsychotic Drug Major Product Offerings
7.4.4 Bristol Myers Squibb Antipsychotic Drug Revenue in Global Market (2018-2023)
7.4.5 Bristol Myers Squibb Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Antipsychotic Drug Major Product Offerings
7.5.4 AstraZeneca Antipsychotic Drug Revenue in Global Market (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Sumitomo Dainippon Pharma
7.6.1 Sumitomo Dainippon Pharma Company Summary
7.6.2 Sumitomo Dainippon Pharma Business Overview
7.6.3 Sumitomo Dainippon Pharma Antipsychotic Drug Major Product Offerings
7.6.4 Sumitomo Dainippon Pharma Antipsychotic Drug Revenue in Global Market (2018-2023)
7.6.5 Sumitomo Dainippon Pharma Key News & Latest Developments
7.7 Allergan
7.7.1 Allergan Company Summary
7.7.2 Allergan Business Overview
7.7.3 Allergan Antipsychotic Drug Major Product Offerings
7.7.4 Allergan Antipsychotic Drug Revenue in Global Market (2018-2023)
7.7.5 Allergan Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Antipsychotic Drug Major Product Offerings
7.8.4 Novartis Antipsychotic Drug Revenue in Global Market (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Cardinal Health
7.9.1 Cardinal Health Company Summary
7.9.2 Cardinal Health Business Overview
7.9.3 Cardinal Health Antipsychotic Drug Major Product Offerings
7.9.4 Cardinal Health Antipsychotic Drug Revenue in Global Market (2018-2023)
7.9.5 Cardinal Health Key News & Latest Developments
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Company Summary
7.10.2 Sun Pharmaceutical Industries Business Overview
7.10.3 Sun Pharmaceutical Industries Antipsychotic Drug Major Product Offerings
7.10.4 Sun Pharmaceutical Industries Antipsychotic Drug Revenue in Global Market (2018-2023)
7.10.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Company Summary
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Antipsychotic Drug Major Product Offerings
7.11.4 GlaxoSmithKline Antipsychotic Drug Revenue in Global Market (2018-2023)
7.11.5 GlaxoSmithKline Key News & Latest Developments
7.12 Sanis Health
7.12.1 Sanis Health Company Summary
7.12.2 Sanis Health Business Overview
7.12.3 Sanis Health Antipsychotic Drug Major Product Offerings
7.12.4 Sanis Health Antipsychotic Drug Revenue in Global Market (2018-2023)
7.12.5 Sanis Health Key News & Latest Developments
7.13 Qilu Pharmaceutical
7.13.1 Qilu Pharmaceutical Company Summary
7.13.2 Qilu Pharmaceutical Business Overview
7.13.3 Qilu Pharmaceutical Antipsychotic Drug Major Product Offerings
7.13.4 Qilu Pharmaceutical Antipsychotic Drug Revenue in Global Market (2018-2023)
7.13.5 Qilu Pharmaceutical Key News & Latest Developments
7.14 Otsuka Pharmaceutical
7.14.1 Otsuka Pharmaceutical Company Summary
7.14.2 Otsuka Pharmaceutical Business Overview
7.14.3 Otsuka Pharmaceutical Antipsychotic Drug Major Product Offerings
7.14.4 Otsuka Pharmaceutical Antipsychotic Drug Revenue in Global Market (2018-2023)
7.14.5 Otsuka Pharmaceutical Key News & Latest Developments
7.15 Vanda Pharmaceuticals
7.15.1 Vanda Pharmaceuticals Company Summary
7.15.2 Vanda Pharmaceuticals Business Overview
7.15.3 Vanda Pharmaceuticals Antipsychotic Drug Major Product Offerings
7.15.4 Vanda Pharmaceuticals Antipsychotic Drug Revenue in Global Market (2018-2023)
7.15.5 Vanda Pharmaceuticals Key News & Latest Developments
7.16 H.Lundbeck
7.16.1 H.Lundbeck Company Summary
7.16.2 H.Lundbeck Business Overview
7.16.3 H.Lundbeck Antipsychotic Drug Major Product Offerings
7.16.4 H.Lundbeck Antipsychotic Drug Revenue in Global Market (2018-2023)
7.16.5 H.Lundbeck Key News & Latest Developments
7.17 Organon
7.17.1 Organon Company Summary
7.17.2 Organon Business Overview
7.17.3 Organon Antipsychotic Drug Major Product Offerings
7.17.4 Organon Antipsychotic Drug Revenue in Global Market (2018-2023)
7.17.5 Organon Key News & Latest Developments
7.18 Hansoh
7.18.1 Hansoh Company Summary
7.18.2 Hansoh Business Overview
7.18.3 Hansoh Antipsychotic Drug Major Product Offerings
7.18.4 Hansoh Antipsychotic Drug Revenue in Global Market (2018-2023)
7.18.5 Hansoh Key News & Latest Developments
7.19 Hengrui
7.19.1 Hengrui Company Summary
7.19.2 Hengrui Business Overview
7.19.3 Hengrui Antipsychotic Drug Major Product Offerings
7.19.4 Hengrui Antipsychotic Drug Revenue in Global Market (2018-2023)
7.19.5 Hengrui Key News & Latest Developments
7.20 Nhwa Group
7.20.1 Nhwa Group Company Summary
7.20.2 Nhwa Group Business Overview
7.20.3 Nhwa Group Antipsychotic Drug Major Product Offerings
7.20.4 Nhwa Group Antipsychotic Drug Revenue in Global Market (2018-2023)
7.20.5 Nhwa Group Key News & Latest Developments
7.21 Yangtze River Pharmaceutical Group
7.21.1 Yangtze River Pharmaceutical Group Company Summary
7.21.2 Yangtze River Pharmaceutical Group Business Overview
7.21.3 Yangtze River Pharmaceutical Group Antipsychotic Drug Major Product Offerings
7.21.4 Yangtze River Pharmaceutical Group Antipsychotic Drug Revenue in Global Market (2018-2023)
7.21.5 Yangtze River Pharmaceutical Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Antipsychotic Drug Market Opportunities & Trends in Global Market
Table 2. Antipsychotic Drug Market Drivers in Global Market
Table 3. Antipsychotic Drug Market Restraints in Global Market
Table 4. Key Players of Antipsychotic Drug in Global Market
Table 5. Top Antipsychotic Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antipsychotic Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antipsychotic Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antipsychotic Drug Product Type
Table 9. List of Global Tier 1 Antipsychotic Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antipsychotic Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Antipsychotic Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Antipsychotic Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antipsychotic Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Antipsychotic Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Antipsychotic Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antipsychotic Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Antipsychotic Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Antipsychotic Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antipsychotic Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Antipsychotic Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antipsychotic Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Antipsychotic Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antipsychotic Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Antipsychotic Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antipsychotic Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Antipsychotic Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antipsychotic Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Antipsychotic Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antipsychotic Drug Revenue, (US$, Mn), 2024-2029
Table 30. Johnson & Johnson Company Summary
Table 31. Johnson & Johnson Antipsychotic Drug Product Offerings
Table 32. Johnson & Johnson Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Johnson & Johnson Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Antipsychotic Drug Product Offerings
Table 36. Pfizer Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Eli Lilly Company Summary
Table 39. Eli Lilly Antipsychotic Drug Product Offerings
Table 40. Eli Lilly Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly Key News & Latest Developments
Table 42. Bristol Myers Squibb Company Summary
Table 43. Bristol Myers Squibb Antipsychotic Drug Product Offerings
Table 44. Bristol Myers Squibb Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol Myers Squibb Key News & Latest Developments
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Antipsychotic Drug Product Offerings
Table 48. AstraZeneca Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Sumitomo Dainippon Pharma Company Summary
Table 51. Sumitomo Dainippon Pharma Antipsychotic Drug Product Offerings
Table 52. Sumitomo Dainippon Pharma Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Sumitomo Dainippon Pharma Key News & Latest Developments
Table 54. Allergan Company Summary
Table 55. Allergan Antipsychotic Drug Product Offerings
Table 56. Allergan Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Allergan Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Antipsychotic Drug Product Offerings
Table 60. Novartis Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Novartis Key News & Latest Developments
Table 62. Cardinal Health Company Summary
Table 63. Cardinal Health Antipsychotic Drug Product Offerings
Table 64. Cardinal Health Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Cardinal Health Key News & Latest Developments
Table 66. Sun Pharmaceutical Industries Company Summary
Table 67. Sun Pharmaceutical Industries Antipsychotic Drug Product Offerings
Table 68. Sun Pharmaceutical Industries Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Sun Pharmaceutical Industries Key News & Latest Developments
Table 70. GlaxoSmithKline Company Summary
Table 71. GlaxoSmithKline Antipsychotic Drug Product Offerings
Table 72. GlaxoSmithKline Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 73. GlaxoSmithKline Key News & Latest Developments
Table 74. Sanis Health Company Summary
Table 75. Sanis Health Antipsychotic Drug Product Offerings
Table 76. Sanis Health Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Sanis Health Key News & Latest Developments
Table 78. Qilu Pharmaceutical Company Summary
Table 79. Qilu Pharmaceutical Antipsychotic Drug Product Offerings
Table 80. Qilu Pharmaceutical Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 81. Qilu Pharmaceutical Key News & Latest Developments
Table 82. Otsuka Pharmaceutical Company Summary
Table 83. Otsuka Pharmaceutical Antipsychotic Drug Product Offerings
Table 84. Otsuka Pharmaceutical Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 85. Otsuka Pharmaceutical Key News & Latest Developments
Table 86. Vanda Pharmaceuticals Company Summary
Table 87. Vanda Pharmaceuticals Antipsychotic Drug Product Offerings
Table 88. Vanda Pharmaceuticals Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 89. Vanda Pharmaceuticals Key News & Latest Developments
Table 90. H.Lundbeck Company Summary
Table 91. H.Lundbeck Antipsychotic Drug Product Offerings
Table 92. H.Lundbeck Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 93. H.Lundbeck Key News & Latest Developments
Table 94. Organon Company Summary
Table 95. Organon Antipsychotic Drug Product Offerings
Table 96. Organon Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 97. Organon Key News & Latest Developments
Table 98. Hansoh Company Summary
Table 99. Hansoh Antipsychotic Drug Product Offerings
Table 100. Hansoh Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 101. Hansoh Key News & Latest Developments
Table 102. Hengrui Company Summary
Table 103. Hengrui Antipsychotic Drug Product Offerings
Table 104. Hengrui Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 105. Hengrui Key News & Latest Developments
Table 106. Nhwa Group Company Summary
Table 107. Nhwa Group Antipsychotic Drug Product Offerings
Table 108. Nhwa Group Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 109. Nhwa Group Key News & Latest Developments
Table 110. Yangtze River Pharmaceutical Group Company Summary
Table 111. Yangtze River Pharmaceutical Group Antipsychotic Drug Product Offerings
Table 112. Yangtze River Pharmaceutical Group Antipsychotic Drug Revenue (US$, Mn) & (2018-2023)
Table 113. Yangtze River Pharmaceutical Group Key News & Latest Developments
List of Figures
Figure 1. Antipsychotic Drug Segment by Type in 2022
Figure 2. Antipsychotic Drug Segment by Application in 2022
Figure 3. Global Antipsychotic Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antipsychotic Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Antipsychotic Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antipsychotic Drug Revenue in 2022
Figure 8. By Type - Global Antipsychotic Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Antipsychotic Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Antipsychotic Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Antipsychotic Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Antipsychotic Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Antipsychotic Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Antipsychotic Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Antipsychotic Drug Revenue Market Share, 2018-2029
Figure 16. US Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Antipsychotic Drug Revenue Market Share, 2018-2029
Figure 20. Germany Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Antipsychotic Drug Revenue Market Share, 2018-2029
Figure 28. China Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Antipsychotic Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Antipsychotic Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Antipsychotic Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Johnson & Johnson Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol Myers Squibb Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AstraZeneca Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sumitomo Dainippon Pharma Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Allergan Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novartis Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cardinal Health Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sun Pharmaceutical Industries Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. GlaxoSmithKline Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sanis Health Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Qilu Pharmaceutical Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Otsuka Pharmaceutical Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Vanda Pharmaceuticals Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. H.Lundbeck Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Organon Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Hansoh Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Hengrui Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Nhwa Group Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Yangtze River Pharmaceutical Group Antipsychotic Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 抗精神病薬の世界市場見通し2023年-2029年(Antipsychotic Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ピモジド抗精神病薬の世界市場見通し2023年-2029年
  • 慢性疲労症候群治療薬の世界市場見通し2023年-2029年
  • 神経疾患治療薬の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆